Lp(a)-related relative risk of future coronary heart disease (CHD) events is similar for individuals at very low absolute risk (0/1 cardiovascular risk factors [CVRF]) and for those at elevated absolute risk with ≥2 CVRFs.
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.